Clinical Trials in New York

Showing 4781-4800 of 22,668 trials

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

NCT06273124

The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS). Participants will be asked to: 1. Wear the EWIS for up to 7 consecutive days for 12 consecutive wear periods 2. Perform blood glucose and ketone measurements if continuous glucose meter is ≥250mg/dL for one hour

Type1diabetes

Tandem Diabetes Care, Inc.260 participantsStarted Mar 2024

Newport Beach, California, United States • Stanford, California, United States • Aurora, Colorado, United States +12 more locations

RECRUITINGNA< 1 mile

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

NCT05380401

A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.

Premature

The University of Texas Health Science Center at San Antonio328 participantsStarted Mar 2023

Los Angeles, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +4 more locations

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Find Trials by Condition in New York

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

Daily Vitamin D for Sickle-cell Respiratory Complications

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy

Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Single-Sided Deafness and Asymmetric Hearing Loss

Adherence Connection for Counseling, Education, and Support (ACCESS) II

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Comparing Hypothermic Temperatures During Hemiarch Surgery

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF)

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors